Biomarin Pharmaceutical (BMRN) Cash from Financing Activities (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Cash from Financing Activities of $2.74 billion for Q2 2026, compared with -$4.6 million a year earlier and up 236.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Biomarin Pharmaceutical was $3.55 billion; for FY2025, it came in at -$42.39 million.
- In prior years, Biomarin Pharmaceutical's Cash from Financing Activities was -$526.45 million in FY2024, -$18.73 million in FY2023, -$18.65 million in FY2022 and -$48,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Cash from Financing Activities in data going back to Q3 2009.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $813.17 million (Q1 2026), $3.16 million (Q4 2025) and -$2.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 2.74 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Bn |
| Mar 31, 2026 | 813.17 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -4.60 Mn |
| Mar 31, 2025 | -38.78 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | -499.13 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | -42.79 Mn |
| Dec 31, 2023 | 10.84 Mn |
| Sep 30, 2023 | -788,000.00 |
| Jun 30, 2023 | 11.96 Mn |
| Mar 31, 2023 | -40.74 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 7.54 Mn |
| Jun 30, 2022 | -11.78 Mn |
| Mar 31, 2022 | -25.28 Mn |
| Dec 31, 2021 | 14.40 Mn |
| Sep 30, 2021 | -1.03 Mn |
API Access
Biomarin Pharmaceutical Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();